Cardiology Letters 2015, 24(2):60-69
The role of melatonin in protecting the heart against malignant arrhythmias
- 1 Ústav pre výskum srdca, SAV, Bratislava
- 2 Fyziologický ústav Lekárská fakulta UK v Bratislave
- 3 Ústav experimentálnej farmakológie a toxikológie SAV, Bratislava
- 4 Fyziologický ústav Bogomoletz, Kyjev, Ukrajina
- 5 Anatomický ústav Lekárská Fakulty UK, Bratislava
- 6 Prírodovedecká fakulta UK, Bratislava, Slovenská republika
Objectives: It is very well known from experimental as well as clinical studies that the pineal hormone, melatonin, which regulates circadian rhythms, exhibits cardioprotective effects. The goal of the study was to confirm our hypothesis and to explore the antiarrhythmic effects of the supplementation of melatonin in hypertensive and normotensive rats. Additionally, we aimed to discover the supposed mechanisms of these effects, i.e. the cooperation of cardiac connexin-43 (Cx43), which provides electrical signal transmission, and the effect of protein kinase C epsilon (PKCε), which modulates Cx43.
Methods: We used spontaneously hypertensive rats (SHR, n=24) and normotensive Wistar rats (n=24) fed with a standard laboratory diet and situated in standard laboratory light conditions (12 hours light/12 hours dark). Melatonin (40 µg/mL) was administered daily to drinking water during the night phase for a duration of five weeks to both hypertensive (n=12) and normotensive (n=12) rats. Systolic blood pressure, biometrical and biochemical parameters were registered at the beginning and at the end of the experiment. The tissue from the left ventricle was used for the analysis of Cx43 and PKCε. The threshold to induce ventricular fibrillation (VF) was tested on an isolated pefused heart setup.
Results: At the onset, plasma levels of melatonin were lower in hypertensive compared to normotensive rats. The exogenous supplementation of melatonin to hypertensive rats resulted in increased plasma levels of melatonin. Moreover, melatonin decreased blood pressure and normalized the level of triglycerides in hypertensive rats, while it decreased body weight and visceral fat in normotensive rats. Heart and left ventricular weight were not affected by melatonin in any of the rat groups. The threshold to induce VF was significantly lower in hypertensive compared to the normotensive rats and significantly increased after the treatment with melatonin. Increased gene expression of Cx43 as well as the expression of Cx43 protein and that of its phosphorylated (functional) forms in the heart of rats exposed to melatonin were also found. Furthermore, the application of melatonin reduced abnormal (proarrythmogenic) myocardial localization of Cx43 in hypertensive rats and increased the expression of PKCε in both groups.
Keywords: hypertensive rats; melatonin; connexin-43; ventricular fibrillation
Published: February 1, 2015 Show citation
References
- Dhein S. Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. Trends Pharmacol Sci 1998;19(6):229-241.
Go to original source... - Severs NJ. Gap junction remodeling and cardiac arrhythmogenesis: cause or coincidence? J Cell Mol Med 2001;5(4):355-366.
Go to original source... - Liu F, Gutstein DE. The cardiac gap junction: a potential therapeutic target in the treatment of heart disease. Mt Sinai J Med 2002;69(6):421-424.
- Tribulova N, Manoach M. Factors determining spontaneous ventricular defibrillation. Exp Clin Cardiol 2001;6(2):109-113.
Go to original source... - Tribulova N, Okruhlicova L, Imanaga I., Hirosawa N, Ogawa K, Weismann P. Factors involved in the susceptibility of spontaneously hypertensive rats to low K+-induced arrhythmias. Gen Physiol Biophys 2003; 22(3):369-382.
- Tribulová N, Knezl V, Okruhlicova Ľ, Slezák J. Myocardial Gap Junctions: Targets for Novel Approaches in the Prevention of LifeThreatening Cardiac Arrhythmias. Physiol Res 2008;57(2):1-13.
Go to original source... - Tribulova N, Seki S, Radosinska J, Kaplan P, Babusikova E, Knezl V, Mochizuki S. Myocardial Ca2+ handling and cell-to-cell coupling, key factors in prevention of sudden cardiac death. Can J Physiol Pharmacol 2009;87(12):1120-1129.
Go to original source... - Bacova B, Radosinska J, Knezl V, Kolenova L, Weismann P, Navarova J, Barancik M, Mitasikova M, Tribulova N. Omega-3 fatty acids and atorvastatin suppress ventricular fibrillation inducibility in hypertriglyceridemic rat hearts: implication of intracellular coupling protein, connexin-43. J Physiol Pharmacol 2010;61(6):717-723.
- Radošinská J, Knezl V, Benová T, Urban L, Tribulová N, Slezák J. Alterations of the intercellular coupling protein, connexin-43, during ventricular fibrillation and sinus rhythm restoration demonstrated in male and female rat hearts: A pilot study. Exp Clin Cardiol 2011;16(4):116-120.
- Radosinska J, Bacova B, Knezl V, Benova T, Zurmanova J, Soukup T, Arnostova P, Slezak J, Gonçalvesova E, Tribulova N. Dietary omega-3 fatty acids attenuate myocardial arrhythmogenic factors and propensity of the heart to lethal arrhythmias in a rodent model of human essential hypertension. J Hypertens 2013;31(9):1876-1885.
Go to original source... - Benova T, Viczenczova C, Radosinska J, Bacova B, Knezl V, Dosenko V, Weismann P, Zeman M, Navarova J, Tribulova N. Melatonin attenuates hypertension-related proarrhythmic myocardial maladaptation of connexin-43 and propensity of the heart to lethal arrhythmias. Can J Physiol Pharmacol 2013;91(8):633-639.
Go to original source... - Peters NS. New insight into myocardial arrhythmogenesis: distribution of gap-junctional coupling in normal, ischemic and hypertrophied human hearts. Clin Sci (Lond) 1996;90:447452.
Go to original source... - Salameh A, Dhein S. Pharmacology of Gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer? Biochim Biophys Acta 2005;1719(1-2):36-58.
Go to original source... - Manoach M, Tribulova N, Vogelezang D, Thomas S, Podzuweit T. Transient ventricular fibrillation and myosin heavy chain isoform profile. J Cell Mol Med 2007;11:171-174.
Go to original source... - Johansson BW. The hibernator heart- Nature's model of resistance to ventricular fibrillation. Cardiovasc Res 1996;31(5):826832.
Go to original source... - Tribulova N, Manoach M. Factors determining spontaneous ventricular defibrillation. Exp. Clin Cardiol 2001;6(2):109-113.
Go to original source... - Saitongdee P, Milner P, Becker DL, Knight GE, Burnstock G. Incerased connexin43 gap junction protein in hamster cardiomyocytes during cold acclimatization and hibernation. Cardiovasc Res 2000;47(1):108-115.
Go to original source... - Sakotnik A, Liebmann PM, Stoschitzky K, Lercher P, Schauenstein K., Klein W, Eber B. Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J 1999;20(18):13141317.
Go to original source... - Girotti L, Lago M, Ianowsky O, Carbajales J, Elizari MV, Brusco LI, Cardinali DP. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery diseases. J Pineal Res 2000;29(3):138-142.
Go to original source... - Jonas M, Garfinkel D, Zisapel N, Laudon M, Grossman E. Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Press 2003;12:19-24.
- Simko F, Paulis L. Antifibrotic effect of melatonin - perspective protection in hypertensive heart disease. Int J Cardiol 2013;168(3):2876-2877.
Go to original source... - Simko F, Pechanova O, Pelouch V, Krajcirovicova K, Mullerova M, Bednarova K, Adamcova M, Paulis L. Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats. J Hypertens Suppl 2009;27(6):5-10.
Go to original source... - Simko F, Pechanova O, Pelouch V, Krajcirovicova K., Celec P, Palffy R, Bednarova K, Vrankova S, Adamcova M, Paulis L. Continu ous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril. J Hypertens 2010;28(1):13-18.
Go to original source... - Zeman M, Dulkova K, Bada V, Herichova I. Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile. Life Sci 2005;76(16):17951803.
Go to original source... - Mitašíková M, Šmidová S, Macsaliová A, Knezl V, Dlugošová K, Okruhlicová Ľ, Weismann P, Tribulová N. Aged Male and Female Spontaneously Hypertensive Rats Benefit from n-3 Polyunsaturated Fatty Acids Supplementation. Physiol Res 2008; 57(2):39-48.
Go to original source... - Radošinská J, Bačová B, Knezl V, Beňová T, Žurmanová J, Soukup T, Arnoštová P, Slezák J, Gonçalvesová E, Tribulová N. Omega-3 polyunsaturated fatty acids affect arrhythmogenic factors and attenuate susceptibility of the heart to malignant arrhythmias in an experimental model of human essential hypertension. Cardiology Lett 2014;23(1):10-16.
- Polontchouk L, Haefliger JA, Ebelt B, Schaefer T, Stuhlmann D, Mehlhorn U, Kuhn-Regnier F, De vivie ER, Dhein S. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 2001;38(3):883-891.
Go to original source... - Bačová B, Radošinská J, Viczenczová C, et al. Up-regulation of myocardial connexin-43 in spontaneously hypertensive rats fed red palm oil is most likely implicated in its anti-arrhythmic effects. Can J Physiol Pharmacol 2012;90:1235-1245.
Go to original source... - Kaneko S, Okumura K, Numaguchi Y, Matsui H, Murase K, Mokuno S, Morishima I, Hira K, Toki Y, Ito T, Hayakawa T. Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemic reperfusion injury. Life Sci 2000;67(2):101-112.
Go to original source... - Szárszoi O, Asemu G, Vaněček J, Ošťádal V, Kolář F. Effects of Melatonin on Ischemia and Reperfusion Injury of the Rat Heart. Cardiovascular Drugs and Therapy 2001;15:251-257.
Go to original source... - Lee YM, Chen HR, Hsiao G, Sheu JR, Wang JJ, Yen MH. Protective effests of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res 2002;33(2):72-80.
Go to original source... - Vazan R, Pancza D, Béder I, Styk J. Ischemia-reperfusion injury-antiarrhythmic effect of melatonin associated with reduced recovering of contractility. Gen Physiol Biophys 2005;24(3):355359.
- Lochner A, Genade S, Davids A, Ytrehus K, Moolman JA. Short-and long-term effects of melatonin on myocardial postischemic recovery. J Pineal Res 2006;40(1):56-63.
Go to original source... - Diez ER, Prados LV, Carrión A, Ponce ZA, Miatello RM. A novel electrophysiologic effect of melatonin on ischemia/reper fusion-induced arrhythmias in isolated rat hearts. J Pineal Res 2009;46(2):155-160.
Go to original source... - Sahna E, Olmez E, Acet A. Effects of physiological and pharmacological concentrations of melatonin on ischemia-reperfusion arrhythmias in rats: can the incidence of sudden cardiac death be reduced? J Pineal Res 2002;32(3):194-198.
Go to original source... - Korkmaz A, Rosales-Corral S, Reiter RJ. Gene regulation by melatonin linked to epigenetic phenomena. Gene 2012;503(1):1-11.
Go to original source... - Sharkey JT, Puttaramu R, Word RA, Olcese J. Melatonin synergizes with oxytocin to enhance contractility of human myometrial smooth muscle cells. J Clin Endocrinol Metab 2009;94(2):421427.
Go to original source... - Mitchell JA, Lye SJ. Regulation of connexin43 expression by c-fos and c-jun in myometrial cells. Cell Commun Adhes 2001;8(46):299-302.
Go to original source... - Cardinali DP, Pévet P. Basic aspects of melatonin action. Sleep Med Rev 1998;2(3):175-190.
Go to original source... - Vanecek J. Cellular mechanisms of melatonin action. Physiol Rev 1998;78(3):687-721.
Go to original source... - Cagnacci A, Arangino S, Angiolucci M, Maschio E, Melis GB. Influences of melatonin administration on the circulation of women. Am J Physiol Regulatory Integrative Comp Physiol 1998;274: 335-338.
Go to original source... - Grossman E, Laudon M, Yalcin R, Zengil H, Peleg E, Sharabi Y, Kamari Y, Shen-Orr Z, Zisapel N. Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med 2006;119(10):898-902.
Go to original source... - Simko F, Paulis L. Melatonin as a potential antihypertensive treatment. J Pineal Res 2007;42(4):319-322.
Go to original source... - Paulis L, Simko F, Laudon M. Cardiovascular effects of melatonin receptor agonists. Expert Opin. Investig Drugs 2012;21(11):1661-1678.
Go to original source... - Paulis L, Pechanova O, Zicha J, Krajcirovicova K, Barta A, Pelouch V, Adamcova M, Simko F. Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NGnitro-L-arginine-methyl ester hypertensive rats. J Hypertens 2009;27(6):11-16.
Go to original source... - Reiter RJ, Guerrero JM, Garcia JJ, Acuńa-Castroviejo D. Reactive Oxygen Intermediates, Molecular Damage, and Aging. Relation to Melatonin. Ann N Y Acad Sci 1998;20:410-424.
Go to original source... - Sakotnik A, Liebmann PM, Stoschitzky K, Lercher P, Schauenstein K, Klein W, Eber B. Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J 1999;20(18):13141317.
Go to original source...

